Verrica Expands YCANTH Rights to Israel in Licensing Deal
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has granted Medomie Pharma Ltd. exclusive rights to seek regulatory approval and commercialize its skin disease treatment YCANTH in Israel, expanding …
Verrica Expands YCANTH Rights to Israel in Licensing Deal Read More